Milestone Pharmaceuticals Inc. MIST
0.76 USD +0.04 (+5.30%)
At closeNov 3, 2026, 6:00 PM EST
0.73 -0.03 -3.81%
After hours · Nov 3, 6:00 PM ET
0.72 Day range 0.7661
0.631 52-week range 3.06
- YTD
- -62.41%
- 1 year
- -58.96%
Analyst view
Price target (mean) 10.25 +1249.9% upside
Now 0.7593
- Target (low)
- 2.00
- Target (mean)
- 10.25
- Target (high)
- 25.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
- Strong buy2
- Buy1
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.15 | -0.16 – -0.14 | -0.32 | +53.1% | 0 | 0.0% | 2 |
| Next quarter | -0.17 | -0.21 – -0.13 | -0.21 | +19.0% | 0 | 0.0% | 2 |
| Current year | -0.61 | -0.64 – -0.58 | -1.39 | +56.1% | 0 | -100.0% | 2 |
| Next year | -0.81 | -1.11 – -0.51 | -0.61 | -32.8% | 6.05M | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 22, 2024 | Rodman & Renshaw | Initiated | — | Buy |
| Jul 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 5, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 27, 2023 | TD Cowen | Maintained | Outperform | Outperform |
| Aug 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 20, 2023 | Jefferies | Downgrade | Buy | Hold |
| May 23, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 12, 2023 | Oppenheimer | Maintained | — | Outperform |
| Mar 30, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 9, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 14, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 22, 2022 | Piper Sandler | Upgrade | Neutral | Overweight |
| Mar 5, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Jul 29, 2020 | Oppenheimer | Upgrade | Perform | Outperform |
| Jul 24, 2020 | Jefferies | Upgrade | Hold | Buy |
| Mar 25, 2020 | Jefferies | Downgrade | Buy | Hold |
| Mar 24, 2020 | Oppenheimer | Downgrade | Outperform | Perform |
| Mar 24, 2020 | Piper Sandler | Downgrade | Overweight | Neutral |
| Jun 3, 2019 | Jefferies | Initiated | — | Buy |
| Jun 3, 2019 | Piper Sandler | Initiated | — | Overweight |